Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
J Postgrad Med. 2023 Jan-Mar;69(1):21-26. doi: 10.4103/jpgm.jpgm_1216_21.
To evaluate questions asked during the informed consent process by adult participants in a COVID-19 vaccine regulatory study conducted at our center in 2020.
After approval by the IEC, informed consent documents and consent narratives were evaluated. We collated the total number and nature of questions. We then looked at the association between education, gender, socio-economic status, employment status, the language of consent, and number of questions. Between-group comparison (female vs male, unemployed vs employed, primary school vs secondary school vs graduate vs post-graduates, upper vs upper-middle vs middle vs lower middle vs lower) for the number of questions asked was done using univariate analysis followed by multivariate regression analysis with post hoc Tukey's test. Independent variables were gender, employment status, education and socioeconomic status and the dependent variable was the number of questions asked by the participant. All analyses were done at 5% significance. Content analysis was done in addition by creating categories after evaluation and coding them.
A total of N = 129 consents from the same number of participants were evaluated. A total of N = 127/129 participants asked at least one question. Sixty-seven percent of participants asked questions related to the study procedure, followed by 44.9% of participants who asked questions related to the safety of vaccine or placebo. A total of N = 295 questions were asked by the 127 participants. In content analysis, 149/295 (50.5%) questions were on study-related procedures followed by one quarter 76/295 (25.8%) based on safety associated with Investigational Product. Very few participants [2.4%] asked about post-trial access as the regulatory trial was a placebo-controlled trial. None of the independent variables were found to be associated with the number of questions.
The majority of the questions asked by the participants were about study-related procedures and vaccine safety. No association was found between any of the independent variables and the number of questions asked. However, there were differences in the demographics of the trial participants between the pandemic and pre-pandemic era.
评估 2020 年在我们中心进行的 COVID-19 疫苗监管研究中,成年参与者在知情同意过程中提出的问题。
在 IEC 批准后,评估了知情同意文件和同意叙述。我们整理了问题的总数和性质。然后,我们研究了教育、性别、社会经济地位、就业状况、同意语言以及问题数量之间的关联。使用单变量分析比较了组间差异(女性与男性、失业与就业、小学与中学与研究生与研究生后),然后使用多元回归分析和事后 Tukey 检验。因变量是参与者提出的问题数量,自变量是性别、就业状况、教育和社会经济地位。所有分析均在 5%的显著性水平下进行。此外,通过评估和编码创建类别后进行内容分析。
共评估了 129 份相同数量参与者的同意书。共有 127/129 名参与者提出了至少一个问题。67%的参与者提出了与研究程序相关的问题,其次是 44.9%的参与者提出了与疫苗或安慰剂安全性相关的问题。127 名参与者共提出 295 个问题。在内容分析中,149/295(50.5%)的问题与研究相关程序有关,其次是四分之一的 76/295(25.8%)与研究相关程序有关与研究产品相关的安全性。很少有参与者(2.4%)询问试验后准入问题,因为监管试验是安慰剂对照试验。没有发现任何独立变量与提出的问题数量有关。
参与者提出的大多数问题都与研究相关程序和疫苗安全性有关。在任何独立变量与提出的问题数量之间都没有发现关联。然而,试验参与者的人口统计学特征在大流行和大流行前时期有所不同。